Global Vaccines Market

A vaccine is a biological preparation that provides immunity against disease. Vaccines are best health interventions available today to prevent infectious diseases such as influenza, measles, mumps and other. Widespread use of vaccines has resulted in considerable progress against some of the most devastating human diseases. Many new approaches are being adopted in development of vaccine such as DNA vaccines, Peptide vaccines which could help in faster antigen detection and induce effective immune response. Further advancement in vaccine preservation techniques, drug delivery systems will facilitate growth in forecast period.

According to the new report Published By Industry Research Place Global Vaccines Market is valued at USD 45.9 Billion in 2019 and is expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period

This report analyses the global market for Vaccines. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.

This Vaccines market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.

Browse the full Report Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook

North America dominates the global vaccine market. The growth in the region was primarily driven by presence of advanced healthcare infrastructure, prevalence of infectious diseases, key players with robust research and development capabilities and growing private and government capital investments for the development of vaccines. Asia Pacific is the fastest growing market which recorded highest CAGR in 2019. Proactive measures of government to tackle the growing infectious diseases, investments on development of healthcare infrastructure, rising prevalence of infectious diseases are some driving the growth of vaccine market in this region. Further developing biopharmaceutical sector has brought significant growth opportunities. The region has large number of vaccine manufacturers offering low cost production solutions for licenced vaccine manufacturers and has seen unprecedented growth in vaccine development. The manufacturers are providing market with innovative products such as cholera vaccines, hepatitis A vaccines, typhoid glycoconjugate vaccine, rotavirus vaccines etc. Rising investments in COVID 19 vaccine production is expected to offer lucrative growth opportunities in future. For instance Chinese biopharmaceutical products company Sinovac Biotech has received $15m funding to advance the development of its CoronaVac Covid-19 vaccine.

Progress has already been made with several therapeutic vaccines for cancer, diabetes, hypertension and Alzheimer’s disease. According to the WHO (World Health Organization) in 2019 were more than 240 vaccines in development for 25 infectious diseases.  HIV/AIDS, malaria, pneumococcal infections, tuberculosis, and Ebola vaccine are the major diseases leading the way. Increasing company initiatives to enhance vaccine R&D, growing prevalence of infectious diseases and exploding population growth are the major drivers for the growth of global vaccine market. In addition to this spread of novel coronavirus around the world has resulted into fast track vaccine development to control the disease. There are 321 candidates in coronavirus vaccine development as of October 2020. Out of which 44 vaccine candidates were conducting clinical trials 34 in Phase I–II trials and 10 in Phase II–III trial. Stringent regulatory policies, complexity of vaccine development, longer clinical trials are factors hampering the growth of global market. Growing investments and on-going research on vaccine developments are expected to foster the market growth in forecast period.

Market Segmentation


oConjugate vaccines

oInactivated and subunit vaccines

oLive attenuated vaccines

oRecombinant vaccines

oToxoid vaccines


oMonovalent vaccines

oMultivalent vaccines

•Patient Type

oPediatric patients

oAdult patients






oHuman Papilloma Virus


oMeningococcal Disease

oPneumococcal disease



Report Coverage

•An overview of the global Vaccines market

•In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market

•Global Vaccines market revenue data historic and forecast analysis (2016 to 2026)

•Characterization and quantification of the market segments for Vaccines market

•Market share analysis of key market participants and their competitive landscape

Inquire Now:

Important Questions Answered by Global Vaccines Market Report

•What is the impact of COVID 19 epidemic on the global Vaccines market?

•Which is mostly affected region, country?

•Which is the current largest and fastest-growing region?

•What is the market size and growth rate of the global Vaccines market?

•What are current factors affecting the growth of market?

•What are Key trends and opportunity areas?

•Within Vaccines market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?

•What are the major strategies adopted by leading market companies?

•What are company challenges and essential success factors by market segment?

•How company offerings and supply chain capabilities are shifting to meet emerging market needs?

About Industry Research Place

Industry research place offers you the best in class market research reports from top publishers. Our reports include credible source of expert insights and actionable solutions for enterprises to size their growth potentials. We partner with leading market analysis companies, research groups, consulting firms, institutes and individual publishers and consultants to provide you latest market findings.

Email us at

Follow Us on:

LinkedIn |Twitter

Leave a Reply

Your email address will not be published. Required fields are marked *